Alignment Healthcare Inc [ALHC] stock is trading at $18.30, up 0.94%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ALHC shares have gain 3.92% over the last week, with a monthly amount glided 35.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on December 03, 2024, when Stephens upgraded its rating to a Overweight and also boosted its price target to $17 from $13. On May 30, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $11 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $10 on May 30, 2024. Piper Sandler upgraded its rating to a Overweight and raised its price target to $8 on May 08, 2024. Barclays started tracking with a Underweight rating for this stock on March 06, 2024, and assigned it a price target of $4.50. In a note dated March 06, 2024, Piper Sandler downgraded an Neutral rating on this stock and revised its target price from $12 to $6.
Alignment Healthcare Inc [ALHC] stock has fluctuated between $4.46 and $18.19 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $18.30 at the most recent close of the market. An investor can expect a potential drop of -18.03% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 2.70B for the trailing twelve months, which represents a growth of 50.68%. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -1.09 and Total Capital is -0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.95 points at the first support level, and at 17.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.55, and for the 2nd resistance point, it is at 18.79.
Ratios To Look Out For
For context, Alignment Healthcare Inc’s Current Ratio is 1.88. Considering the valuation of this stock, the price to sales ratio is 1.30, the price to book ratio is 35.15.
Transactions by insiders
Recent insider trading involved Scavo Robert L., Chief Information Officer, that happened on Mar 27 ’25 when 2864.0 shares were sold. Chief Experience Officer, Kardes Hakan completed a deal on Mar 27 ’25 to sell 7225.0 shares. Meanwhile, President Maroney Dawn Christine sold 11152.0 shares on Mar 27 ’25.
